Fibroids in Women of Reproductive Age and Women Pregnancy

Phase 4CompletedNCT02620345

Trieu, Nguyen Thi, M.D.22 enrolled

Overview

Dydrogesterone Multivitamin Nature treatment of fibroids in women of reproductive age and women pregnancy to lost the size fibroids.

Uterine fibroids are a very common finding in women of reproductive age. But may fibroids grow in the first trimester pregnancy. Clinically has shown that: Uterine fibroids are associated with an Heavy or prolonged menstrual periods. Abnormal bleeding between menstrual periods. Uterine fibroids are associated with an increased rate of spontaneous miscarriage, preterm labor, placenta abruption, malpresentation, labor dystocia, cesarean delivery, and postpartum hemorrhage, pain is the most common complication of fibroids during pregnancy. Can usually be controlled by conservative treatment on Dydrogesterone Multivitamin nature.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Fibroids

Interventions

Dydrogesterone M ( case 1 )DRUG

Dydrogesterone Multivitamin nature * Fibroids / Women Pregnancy ( discovered fibroids during pregnancy ) Dydrogesterone Multivitamin nature. * 1tablet/24 hours/day (to 4 weeks after postpartum)

Dydrogesterone M ( case 2 )DRUG

Dydrogesterone Multivitamin nature * Fibroids/ Women of Reproductive age ( discovered fibroids ) * 1tablet/24 hours/day ( from discovered fibroids through 6 months)

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Procedure to treatment of fibroids in pregnancy and in women desiring future fertility. Exclusion Criteria: * Whether or not you are having symptoms from the fibroids * If you might want to become pregnant in the future * The size of the fibroids * The location of the fibroids * Your age and you might be

Outcomes

Primary Outcomes

Measure of fibroid size in millimeters

* Patients fulfilling inclusion and exclusion criteria. * Measure to have Fibroids size \> 50mm x 60mm. * Will be divided into two groups Group (A): Women Pregnancy. * Measure of fibroid size in millimeters \< 50mm x 60mm. Group (B): Women Reproductive age. * Measure of fibroid size in millimeters \< 50mm x 60mm.

Time frame: from 4 weeks to 20 weeks

Secondary Outcomes

Measure of fibroid size in millimeters

Group (A):Women Pregnancy. \- Measure of fibroid size in millimeters to loss the fibroids. Group (B): Women Reproductive age \- Measure of fibroid size in millimeters to loss the fibroids.

Time frame: from 20 weeks to 48 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.